Clinical trials
Phase 2 Recurrence trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
73 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 3 |
| 2006 | 4 |
| 2007 | 7 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 4 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 5 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 2 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 50 |
| Recruiting | 10 |
| Terminated | 10 |
| Active, not recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 6 |
| AstraZeneca | 5 |
| Novartis Pharmaceuticals | 5 |
| University Health Network, Toronto | 5 |
| Children's Oncology Group | 3 |
| GlaxoSmithKline | 3 |
| Pfizer | 3 |
| Mirati Therapeutics Inc. | 2 |
| Sanofi | 2 |
| pharmaand GmbH | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 73 |
| Multiple Myeloma | 11 |
| Neoplasms | 9 |
| Leukemia | 8 |
| Lymphoma | 8 |
| Leukemia, Myeloid, Acute | 6 |
| Lymphoma, Large B-Cell, Diffuse | 6 |
| Lymphoma, Non-Hodgkin | 6 |
| Neoplasm Metastasis | 5 |
| Head and Neck Neoplasms | 4 |
Trials
Showing 1 to 25 of 73. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.